Dashboard
Manage Tickers

DRRXDURECT CORP

Nasdaq durect.com


$ 1.46 $ 0.03 (2.1 %)    

Monday, 26-Aug-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 1.46
$ 1.46
$ 1.46 x 200
-- x --
$ 1.45 - $ 1.46
$ 0.47 - $ 3.25
44,116
na
45.32M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 08-10-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 03-05-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-08-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-02-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-01-2016 12-31-2015 10-K
35 11-03-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 03-03-2015 12-31-2014 10-K
39 11-04-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

durect-q2-2024-gaap-eps-012-beats-017-estimate-sales-2171m-miss-2492m-estimate
Durect Q2 2024 GAAP EPS $(0.12) Beats $(0....
08/13/2024 20:06:24

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 29....

hc-wainwright--co-reiterates-neutral-on-durect
HC Wainwright & Co. Reiterates Neutral on ...
05/22/2024 10:26:30

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 20:31:00

watching-durect-traders-circulate-unconfirmed-analyst-comments-suggesting-a-5-pt-on-the-stock-after-fda-feedback
Watching DURECT; Traders Circulate Unconfi...
05/21/2024 18:52:22

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 12:06:31

durect-corporation-receives-fda-breakthrough-therapy-designation-for-larsucosterol-in-alcohol-associated-hepatitis
DURECT Corporation Receives FDA Breakthrou...
05/21/2024 12:03:36

hc-wainwright--co-reiterates-neutral-on-durect
HC Wainwright & Co. Reiterates Neutral on ...
05/15/2024 14:53:13

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.

durect-q1-2024-eps-025-up-from-052-yoy-revenue-18m-down-from-21m-yoy
DURECT Q1 2024 EPS $(0.25) Up From $(0.52)...
05/13/2024 20:08:04

oppenheimer-reiterates-outperform-on-durect-maintains-5-price-target
Oppenheimer Reiterates Outperform on Durec...
04/01/2024 13:19:43

Oppenheimer analyst Francois Brisebois reiterates Durect (NASDAQ:DRRX) with a Outperform and maintains $5 price target.

hc-wainwright--co-reiterates-neutral-on-durect
HC Wainwright & Co. Reiterates Neutral on ...
03/28/2024 12:11:37

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.

durect-q4-earnings-insights
Durect: Q4 Earnings Insights
03/27/2024 20:15:14

durect-q4-2023-gaap-eps-010-beats-033-estimate-sales-2669m-beat-2477m-estimate
Durect Q4 2023 GAAP EPS $(0.10) Beats $(0....
03/27/2024 20:05:11

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.33) by 69....

earnings-scheduled-for-march-27-2024
Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

durects-earnings-a-preview
Durect's Earnings: A Preview
03/26/2024 16:01:49

durect-corp-has-regained-compliance-with-nasdaq-listing-rule-5550a2-for-continued-listing-on-nasdaq-capital-market
DURECT Corp Has Regained Compliance With N...
03/22/2024 20:09:04

- SEC Filing

Core News & Articles
Durect Corporation Has Entered Into A Co-m...
03/04/2024 12:02:35

top-3-health-care-stocks-that-are-preparing-to-pump-this-month
Top 3 Health Care Stocks That Are Preparin...
12/18/2023 12:39:29

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
11/22/2023 21:31:02

recap-durect-q3-earnings
Recap: Durect Q3 Earnings
11/13/2023 21:15:11

durect-q3-2023-gaap-eps-014-beats-042-estimate-sales-174m-miss-297m-estimate
Durect Q3 2023 Gaap EPS $(0.14) Beats $(0....
11/13/2023 21:14:09

Durect (NASDAQ:DRRX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.42) by 66....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION